ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Combination With Fludarabine and Cytarabine, in Pediatric Relapsed or Refractory Acute Leukemia.

Thomas B Alexander et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.